ICISi Masterclass

Masterclass in Imaging of Prostate Cancer

4th November, 2021 8:30 AM

Live Via Zoom

Online

This second edition online Masterclass in Imaging of Prostate Cancer is a highly commended one-day teaching course which will highlight current imaging techniques, image interpretation and pitfalls in imaging prostate cancer.

Overview

A stimulating and engaging learning experience – reviewing cases with the experts!

The online ICIS Interactive series is designed as an advanced cancer imaging course for Radiologists, who would like to gain deeper understanding into the imaging of specific cancers through case-based learning. The courses in this series have been rated excellent by many participants.

This one-day online masterclass comprises four sessions, as outlined in the programme. Presentation of each topic will commence with a lecture followed by mentored review of 8-10 carefully selected cases to facilitate hands-on case-based learning.

Delegates are advised to use two screens on the day, which can be a PC and tablet/laptop. As this is an interactive course, we ask that you join using a device with a camera to achieve the optimal experience.

A comprehensive workbook to reinforce learning is provided to guide participants through the cases, with each case chosen to illustrate specific learning points. In advance of the course we will courier a printed & bound copy of the workbook, for you to work through.

By the end of the course, all participants will have benefitted from mentored case-based learning of 35 - 40 cases, each chosen with specific learning points.

Learning Objectives

To understand the prostate patient’s journey from suspected cancer to the advanced disease state using the framework of definable clinical states.
To know in detail the pathologic states, problems of categorisation and clinical needs of patients in each clinical state in the prostate cancer pathway.
To understand how imaging can help meet clinical priorities and so promote the personalisation of care in the advancing prostate cancer pathway.
To show how next generation prostate imaging (multiparametric MRI & MR-directed biopsies) and whole body assessments (whole body MRI & PET/CT) with clinical biomarkers, create opportunities to support and refine management pathways of patients.